secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001477449-26-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q4 revenue flat at $642M, net loss narrows; FY2026 revenue guidance $2.47-2.587B
--------------------------------------------------------------------------------

- Q4 2025 revenue $642.3M (flat YoY); net loss $25.1M vs $48.4M loss; adjusted EBITDA $83.8M (+12% YoY).
- Full year 2025 revenue $2.53B (-2% YoY); net loss $200.3M vs $1.001B loss (lower goodwill impairment).
- Integrated Care segment revenue +5% in Q4; BetterHelp -7%. FY Integrated Care adjusted EBITDA +3% to $239.2M.
- FY2026 revenue guidance $2.47-2.587B; adjusted EBITDA $266-308M; free cash flow $130-170M.
- Cash and equivalents $781.1M at year-end; Q4 free cash flow $53.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000010/0001477449-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000010/tdoc-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001477449-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer